Literature DB >> 27550968

Trajectories of Cardiovascular Risk Factors and Incidence of Atrial Fibrillation Over a 25-Year Follow-Up: The ARIC Study (Atherosclerosis Risk in Communities).

Faye L Norby1, Elsayed Z Soliman2, Lin Y Chen2, Lindsay G S Bengtson2, Laura R Loehr2, Sunil K Agarwal2, Alvaro Alonso2.   

Abstract

BACKGROUND: Timing and trajectories of cardiovascular risk factor (CVRF) development in relation to atrial fibrillation (AF) have not been described previously. We assessed trajectories of CVRF and incidence of AF over 25 years in the ARIC study (Atherosclerosis Risk in Communities).
METHODS: We assessed trajectories of CVRF in 2456 individuals with incident AF and 6414 matched control subjects. Subsequently, we determined the association of CVRF trajectories with the incidence of AF among 10 559 AF-free individuals (mean age, 67 years; 52% men; 20% blacks). Risk factors were measured during 5 examinations between 1987 and 2013. Cardiovascular events, including incident AF, were ascertained continuously. We modeled the prevalence of risk factors and cardiovascular outcomes in the period before and after AF diagnosis and the corresponding index date for control subjects using generalized estimating equations. Trajectories in risk factors were identified with latent mixture modeling. The risk of incident AF by trajectory group was examined with Cox models.
RESULTS: The prevalence of stroke, myocardial infarction, and heart failure increased steeply during the time close to AF diagnosis. All CVRFs were elevated in AF cases compared with controls >15 years before diagnosis. We identified distinct trajectories for all the assessed CVRFs. In general, individuals with trajectories denoting long-term exposure to CVRFs had increased AF risk even after adjustment for single measurements of the CVRFs.
CONCLUSIONS: AF patients have increased prevalence of CVRF many years before disease diagnosis. This analysis identified diverse trajectories in the prevalence of these risk factors, highlighting their different roles in AF pathogenesis.
© 2016 American Heart Association, Inc.

Entities:  

Keywords:  atrial fibrillation; cardiovascular diseases; epidemiology

Mesh:

Year:  2016        PMID: 27550968      PMCID: PMC4999250          DOI: 10.1161/CIRCULATIONAHA.115.020090

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  39 in total

1.  Stroke incidence and survival among middle-aged adults: 9-year follow-up of the Atherosclerosis Risk in Communities (ARIC) cohort.

Authors:  W D Rosamond; A R Folsom; L E Chambless; C H Wang; P G McGovern; G Howard; L S Copper; E Shahar
Journal:  Stroke       Date:  1999-04       Impact factor: 7.914

2.  Temporal trends in the occurrence and outcomes of atrial fibrillation in patients with acute myocardial infarction (from the Atherosclerosis Risk in Communities Surveillance Study).

Authors:  Lindsay G S Bengtson; Lin Y Chen; Alanna M Chamberlain; Erin D Michos; Eric A Whitsel; Pamela L Lutsey; Sue Duval; Wayne D Rosamond; Alvaro Alonso
Journal:  Am J Cardiol       Date:  2014-06-18       Impact factor: 2.778

Review 3.  Mortality associated with atrial fibrillation in patients with myocardial infarction: a systematic review and meta-analysis.

Authors:  Patricia Jabre; Véronique L Roger; Mohammad H Murad; Alanna M Chamberlain; Larry Prokop; Frédéric Adnet; Xavier Jouven
Journal:  Circulation       Date:  2011-04-04       Impact factor: 29.690

4.  Incidence of and risk factors for atrial fibrillation in older adults.

Authors:  B M Psaty; T A Manolio; L H Kuller; R A Kronmal; M Cushman; L P Fried; R White; C D Furberg; P M Rautaharju
Journal:  Circulation       Date:  1997-10-07       Impact factor: 29.690

5.  Temporal relations of atrial fibrillation and congestive heart failure and their joint influence on mortality: the Framingham Heart Study.

Authors:  Thomas J Wang; Martin G Larson; Daniel Levy; Ramachandran S Vasan; Eric P Leip; Philip A Wolf; Ralph B D'Agostino; Joanne M Murabito; William B Kannel; Emelia J Benjamin
Journal:  Circulation       Date:  2003-05-27       Impact factor: 29.690

Review 6.  Atrial fibrillation: hypertension as a causative agent, risk factor for complications, and potential therapeutic target.

Authors:  Jeff S Healey; Stuart J Connolly
Journal:  Am J Cardiol       Date:  2003-05-22       Impact factor: 2.778

7.  Cardiac and pulmonary causes of dyspnoea--validation of a scoring test for clinical-epidemiological use: the Study of Men Born in 1913.

Authors:  H Eriksson; K Caidahl; B Larsson; L O Ohlson; L Welin; L Wilhelmsen; K Svärdsudd
Journal:  Eur Heart J       Date:  1987-09       Impact factor: 29.983

8.  The Atherosclerosis Risk in Communities (ARIC) Study: design and objectives. The ARIC investigators.

Authors: 
Journal:  Am J Epidemiol       Date:  1989-04       Impact factor: 4.897

9.  Incidence of atrial fibrillation in whites and African-Americans: the Atherosclerosis Risk in Communities (ARIC) study.

Authors:  Alvaro Alonso; Sunil K Agarwal; Elsayed Z Soliman; Marietta Ambrose; Alanna M Chamberlain; Ronald J Prineas; Aaron R Folsom
Journal:  Am Heart J       Date:  2009-07       Impact factor: 4.749

10.  Simple risk model predicts incidence of atrial fibrillation in a racially and geographically diverse population: the CHARGE-AF consortium.

Authors:  Alvaro Alonso; Bouwe P Krijthe; Thor Aspelund; Katherine A Stepas; Michael J Pencina; Carlee B Moser; Moritz F Sinner; Nona Sotoodehnia; João D Fontes; A Cecile J W Janssens; Richard A Kronmal; Jared W Magnani; Jacqueline C Witteman; Alanna M Chamberlain; Steven A Lubitz; Renate B Schnabel; Sunil K Agarwal; David D McManus; Patrick T Ellinor; Martin G Larson; Gregory L Burke; Lenore J Launer; Albert Hofman; Daniel Levy; John S Gottdiener; Stefan Kääb; David Couper; Tamara B Harris; Elsayed Z Soliman; Bruno H C Stricker; Vilmundur Gudnason; Susan R Heckbert; Emelia J Benjamin
Journal:  J Am Heart Assoc       Date:  2013-03-18       Impact factor: 5.501

View more
  19 in total

1.  Etanercept With IVIg for Acute Kawasaki Disease: A Randomized Controlled Trial.

Authors:  Michael A Portman; Nagib S Dahdah; April Slee; Aaron K Olson; Nadine F Choueiter; Brian D Soriano; Sujatha Buddhe; Carolyn A Altman
Journal:  Pediatrics       Date:  2019-05-02       Impact factor: 7.124

Review 2.  Influence of Inflammation and Atherosclerosis in Atrial Fibrillation.

Authors:  Rose Mary Ferreira Lisboa da Silva
Journal:  Curr Atheroscler Rep       Date:  2017-01       Impact factor: 5.113

3.  Heart Failure and Cognitive Impairment in the Atherosclerosis Risk in Communities (ARIC) Study.

Authors:  Lucy S Witt; Jason Rotter; Sally C Stearns; Rebecca F Gottesman; Anna M Kucharska-Newton; A Richey Sharrett; Lisa M Wruck; Jan Bressler; Carla A Sueta; Patricia P Chang
Journal:  J Gen Intern Med       Date:  2018-07-20       Impact factor: 5.128

4.  Multisystem Trajectories Over the Adult Life Course and Relations to Cardiovascular Disease and Death.

Authors:  Teemu J Niiranen; Danielle M Enserro; Martin G Larson; Ramachandran S Vasan
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2019-10-04       Impact factor: 6.053

5.  Galectin-3 and incidence of atrial fibrillation: The Atherosclerosis Risk in Communities (ARIC) study.

Authors:  Oluwaseun E Fashanu; Faye L Norby; David Aguilar; Christie M Ballantyne; Ron C Hoogeveen; Lin Y Chen; Elsayed Z Soliman; Alvaro Alonso; Aaron R Folsom
Journal:  Am Heart J       Date:  2017-07-08       Impact factor: 4.749

Review 6.  Predisposing factors for atrial fibrillation in the elderly.

Authors:  Kristina Wasmer; Lars Eckardt; Günter Breithardt
Journal:  J Geriatr Cardiol       Date:  2017-03       Impact factor: 3.327

7.  Long-Term Exposure to Elevated Systolic Blood Pressure in Predicting Incident Cardiovascular Disease: Evidence From Large-Scale Routine Electronic Health Records.

Authors:  Jose Roberto Ayala Solares; Dexter Canoy; Francesca Elisa Diletta Raimondi; Yajie Zhu; Abdelaali Hassaine; Gholamreza Salimi-Khorshidi; Jenny Tran; Emma Copland; Mariagrazia Zottoli; Ana-Catarina Pinho-Gomes; Milad Nazarzadeh; Kazem Rahimi
Journal:  J Am Heart Assoc       Date:  2019-06-05       Impact factor: 5.501

8.  Life course trajectories of cardiovascular risk: Impact on atherosclerotic and metabolic indicators.

Authors:  Benjamin D Pollock; Patrick Stuchlik; Emily W Harville; Katherine T Mills; Wan Tang; Wei Chen; Lydia A Bazzano
Journal:  Atherosclerosis       Date:  2018-11-08       Impact factor: 5.162

9.  Evolution of Cardiovascular Risk Factors in a Worker Cohort: A Cluster Analysis.

Authors:  Sara Castel-Feced; Lina Maldonado; Isabel Aguilar-Palacio; Sara Malo; Belén Moreno-Franco; Eusebio Mur-Vispe; José-Tomás Alcalá-Nalvaiz; María José Rabanaque-Hernández
Journal:  Int J Environ Res Public Health       Date:  2021-05-24       Impact factor: 3.390

10.  Heart Failure and Frailty in the Community-Living Elderly Population: What the UFO Study Will Tell Us.

Authors:  Erik Fung; Elsie Hui; Xiaobo Yang; Leong T Lui; King F Cheng; Qi Li; Yiting Fan; Daljit S Sahota; Bosco H M Ma; Jenny S W Lee; Alex P W Lee; Jean Woo
Journal:  Front Physiol       Date:  2018-04-24       Impact factor: 4.566

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.